Ziprasidone: Long-term post-switch efficacy in schizophrenia

被引：2
|
作者：
Dunn, J
Simpson, GM
Fayek, M
Weiden, PJ
Murray, S
Warrington, L
Loebel, A
机构：
[1] Pfizer Inc, CNS Med, New York, NY USA
[2] Univ So Calif, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA
[3] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80305-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 50 条
  • [1] Ziprasidone: Long-term post-switch efficacy in schizophrenia
    Simpson, GM
    Fayek, M
    Weiden, P
    Murray, S
    Dunn, J
    Warrington, L
    Loebel, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S415 - S415
  • [2] Long-term post-switch efficacy in schizophrenia
    Simpson, GM
    Fayek, M
    Weiden, PJ
    Murray, S
    Dunn, J
    Warrington, L
    Loebel, A
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 79S - 79S
  • [3] Ziprasidone's long-term efficacy and tolerability in schizophrenia
    Meltzer, HY
    [J]. EUROPEAN PSYCHIATRY, 2002, 17 : 101S - 101S
  • [4] Long-term efficacy of ziprasidone in treatment-refractory schizophrenia
    Potkin, SG
    Loebel, A
    Kane, J
    Siu, C
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S269 - S269
  • [5] Long-term efficacy of ziprasidone in schizophrenia: Results of three controlled trials
    Meltzer, HY
    O'Connor, R
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 239 - 239
  • [6] Ziprasidone's long-term efficacy in treatment-refractory schizophrenia
    Kane, JM
    Khanna, S
    Giller, EL
    Rajadhyaksha, S
    Loebel, A
    Siu, C
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 52S - 53S
  • [7] Ziprasidone in treatment-resistant schizophrenia: Long-term efficacy and tolerability
    Dunn, J
    Kane, J
    Khanna, S
    Giller, E
    Rajadhyaksha, S
    Loebel, A
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 481 - 482
  • [8] Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia
    Simpson, George M.
    O'Gorman, Cedric J.
    Loebel, Antony
    Yang, Ruoyong
    [J]. CNS SPECTRUMS, 2008, 13 (10) : 898 - 905
  • [9] Ziprasidone negative symptom efficacy in long-term clinical trials
    Schooler, NR
    Murray, S
    Siu, CO
    Romano, SJ
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S301 - S301
  • [10] Ziprasidone's long-term efficacy and safety in bipolar disorder
    Dunn, J
    Keck, PE
    Potkin, SG
    Giller, E
    Ice, K
    Warrington, L
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 180S - 180S
12345